ClinicalTrials.gg
Status unknownNCT04844437ITUSRUpdated Mar 21, 2023

Intrapartum Translabial Ultrasonography Reliability

An observational study in Labour;Obstructed, Progression and Delivery Problem for Fetus, sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Status unknown at 1 site in Turkey. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
80
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

In a present study vaginal examination of the fetal head station is compared with transperineal ultrasonography evaluation of fetal head station and the ability of ultrasonography evaluation in predicting the time and mode of delivery will be investigated.

Read the detailed description

The sonographically measured head station, 'ITU station', was measured along the longest visible axis of the fetal head, between the intersections with the infra pubic line and the deepest bony part of the fetal head, subtracting 3 cm for the level of the ischial spines. This parameter is useful to determine the level of engagement of the fetal head and its progression throughout labor.

The labor is divided into a latent phase (stage 0), an active phase (stage 1 and 2), and a third stage defined as the time period between the delivery of the baby and the delivery of the placenta. According to the classic definition, the onset of labor is when regular contractions have been established. The latent phase is characterized by painful contractions and cervical dilatation up to 5 cm in accordance with WHO.

The fetal descent in the birth canal is assessed by vaginal digital examinations and related to the ischial spine. ACOG has defined five stations above (-5) and below (+5) the level of the spine (0 stations). Minus five corresponds to the pelvic inlet, zero to the level of the ischial spine, and plus four corresponds to the pelvic floor.

Traditionally, labor progression has been assessed by digital examination of cervical dilatation and fetal descent. Recent studies, however, dispute these findings and found the clinical examination of fetal descent and position to be unprecise and subjective with a high interobserver variation. Dupuis et al. made an important contribution to this debate when he rigorously assessed the accuracy of station diagnosis with digital examinations. . This study provides evidence that digital assessment of fetal head station is unreliable.

However, a study from 2019 found a good correlation between clinical assessments and ultrasound examinations when only one experienced clinician and one trained ultrasound examiner compared their results.

In this study, we aim to evaluate the accuracy of and consistency between vaginal examination and transperineal ultrasound head station measurements.

02

Conditions studied

  • Labour;Obstructed
  • Progression
  • Delivery Problem for Fetus
  • Ultrasound Therapy; Complications

Keywords

  • labor
  • intrapartum ultrasonography
  • head station
03

In context

Dystocia

55 studies on the registry are indexed under Dystocia; 12 are open to participants now.

This study's planned enrollment of 80 is below the median of 212 across 12 observational studies indexed under Dystocia.

Browse Dystocia studies →

Lead sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital is the lead sponsor of 41 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Pregnant women at 36 weeks or over gestational weeks at the active phase of the first stage and the second stage of labor.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At or over 36 weeks pregnant women
  • Pregnant women at the active phase of the first stage of labor
  • Pregnant women at the second stage of labor

Exclusion criteria

Exclusion Criteria:

  • Breech presentation
  • Fetal anomaly
  • In utero ex fetus cases
  • Trial of labor after cesarean cases
  • Pregnant women at the latent phase of the first sage of labor
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
80 participants (estimated)
Target follow-up
2 Days
Patient registry
Yes

Groups and cohorts

  • Digital examination of fetal head decent in pregnant women

    Pregnant women at 36 weeks or over gestational age in the active phase of the first stage or second stage of labor were examined by digital examination and fetal head station evaluated by two clinicians.

  • Transperineal assessment of fetal head decent in pregnant women

    Pregnant women at 36 weeks or over gestational age in the active phase of the first stage or second stage of labor were examined by transperineal ultrasound and fetal head station evaluated by two experienced clinicians.

    Diagnostic Test: Transperineal ultrasound

Interventions

  • Diagnostic testTransperineal ultrasound

    The fetal head station is evaluated by transperineal ultrasonography in valsalva.

06

What researchers measure

Primary outcomes

  1. Acuracy of the fetal head progression distance

    Transperineal measurement of fetal head station will be compared with vaginal examination of fetal head descent and these two measurements correlated with delivery outcomes

    Time frame: At any time in active phase of first stage or second stage of labor

Secondary outcomes

  1. Interobserver agreement between vaginal examination fetal head station

    The examination of fetal head levels by two clinicians compared with eachother.

    Time frame: At any time in active phase of first stage or second stage of labor

  2. Interobserver agreement between ultrasonographic fetal head station measurement

    The correlation between two clinicians in measuring ultrasonographic fetal head station.

    Time frame: At any time in active phase of first stage or second stage of labor

07

Study locations

1 site
  • Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital
    Istanbul, Turkey
08

References and documents

Publications

  • Ciaciura-Jarno M, Cnota W, Wojtowicz D, Niesluchowska-Hoxha A, Ruci A, Kierach R, Stepien A, Nowak A, Sodowska P. Evaluation of selected ultrasonography parameters in the second stage of labor in prediction mode of delivery. Ginekol Pol. 2016;87(6):448-53. doi: 10.5603/GP.2016.0024. PubMed 27418223 ↗
  • Akmal S, Kametas N, Tsoi E, Hargreaves C, Nicolaides KH. Comparison of transvaginal digital examination with intrapartum sonography to determine fetal head position before instrumental delivery. Ultrasound Obstet Gynecol. 2003 May;21(5):437-40. doi: 10.1002/uog.103. PubMed 12768552 ↗
  • Ramphul M, Ooi PV, Burke G, Kennelly MM, Said SA, Montgomery AA, Murphy DJ. Instrumental delivery and ultrasound : a multicentre randomised controlled trial of ultrasound assessment of the fetal head position versus standard care as an approach to prevent morbidity at instrumental delivery. BJOG. 2014 Jul;121(8):1029-38. doi: 10.1111/1471-0528.12810. Epub 2014 Apr 11. PubMed 24720273 ↗
  • Dupuis O, Silveira R, Zentner A, Dittmar A, Gaucherand P, Cucherat M, Redarce T, Rudigoz RC. Birth simulator: reliability of transvaginal assessment of fetal head station as defined by the American College of Obstetricians and Gynecologists classification. Am J Obstet Gynecol. 2005 Mar;192(3):868-74. doi: 10.1016/j.ajog.2004.09.028. PubMed 15746684 ↗
  • Iversen JK, Jacobsen AF, Mikkelsen TF, Eggebo TM. Structured clinical examinations in labor: rekindling the craft of obstetrics. J Matern Fetal Neonatal Med. 2021 Jun;34(12):1963-1969. doi: 10.1080/14767058.2019.1651283. Epub 2019 Aug 19. PubMed 31422727 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2021 to primary completion in Sep 2022, 19 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2021
First posted
Apr 14, 2021
StartActual
Feb 20, 2021
Primary completionActual
Sep 30, 2022
CompletionEst.
Mar 30, 2023
Last update
Mar 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04844437
Lead sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Responsible party
Arzu Bilge Tekin (Specialist, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital) — Principal investigator
First posted
Apr 14, 2021
Start date
Feb 20, 2021
Primary completion
Sep 30, 2022
Completion
Mar 30, 2023 (estimated)
Last update
Mar 21, 2023

Study contacts

Murat Yassa, MD
study director · Specialist

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion